Replimune Group Inc. (CLIP) Insider Ownership Change
Ticker: REPL · Form: 4 · Filed: 2026-04-07T21:08:32-04:00
Sentiment: neutral
Topics: insider-filing, ownership-change
Related Tickers: CLIP
TL;DR
Insider Joseph Slattery changed ownership in Replimune Group Inc. on 4/1/26.
AI Summary
On April 1, 2026, Joseph P. Slattery, a reporting person for Replimune Group, Inc., reported a change in beneficial ownership of securities. The filing details transactions related to Replimune Group, Inc., a biotechnology company focused on oncolytic immunotherapies.
Why It Matters
This filing indicates a change in the beneficial ownership of securities by an insider, which can provide insights into the insider's confidence in the company's future prospects.
Risk Assessment
Risk Level: low — Form 4 filings typically report routine changes in insider holdings and do not inherently signal significant risk.
Key Players & Entities
- Replimune Group, Inc. (company) — Issuer
- Joseph P. Slattery (person) — Reporting Person
- 0001737953 (company) — Replimune Group, Inc. CIK
- 0001246530 (person) — Joseph P. Slattery CIK
FAQ
What is the specific nature of the change in beneficial ownership reported by Joseph P. Slattery?
The filing is a Form 4, which reports changes in beneficial ownership. Specific transaction details would be found within the document itself, but the summary indicates a change occurred on April 1, 2026.
What is Replimune Group, Inc.'s primary business focus?
Replimune Group, Inc. is focused on Biological Products, specifically oncolytic immunotherapies.
When was the period of report for this filing?
The period of report was April 1, 2026.
What is the CIK number for Replimune Group, Inc.?
The CIK number for Replimune Group, Inc. is 0001737953.
Who is the reporting person mentioned in the filing?
The reporting person mentioned is Joseph P. Slattery, with CIK 0001246530.
From the Filing
EDGAR Filing Documents for 0001104659-26-040568 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001104659-26-040568 Filing Date 2026-04-07 Accepted 2026-04-07 21:08:32 Documents 1 Period of Report 2026-04-01 Document Format Files Seq Description Document Type Size 1 OWNERSHIP DOCUMENT tm2611350-3_4seq1.html 4 1 OWNERSHIP DOCUMENT tm2611350-3_4seq1.xml 4 4122 Complete submission text file 0001104659-26-040568.txt 5568 Mailing Address C/O TRANSENTERIX, INC. 635 DAVIS DRIVE, SUITE 300 MORRISVILLE NC 27560 Business Address SLATTERY JOSEPH P ( Reporting ) CIK : 0001246530 (see all company filings) Type: 4 | Act: 34 | File No.: 001-38596 | Film No.: 26846260 Mailing Address 500 UNICORN PARK WOBURN MA 01801 Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600 Replimune Group, Inc. ( Issuer ) CIK : 0001737953 (see all company filings) EIN. : 822082553 | State of Incorp.: DE | Fiscal Year End: 0331 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)